Click for best price
Allogeneic Stem Cell Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cell Therapy. This report contains market size and forecasts of Allogeneic Stem Cell Therapy in global, including the following market information:
Global Allogeneic Stem Cell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Allogeneic Stem Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Adult Stem Cell Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Allogeneic Stem Cell Therapy include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen and MolMed S.p.A., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Allogeneic Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Allogeneic Stem Cell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Allogeneic Stem Cell Therapy Market Segment Percentages, by Type, 2022 (%)
Adult Stem Cell Therapy
Human Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Others
Global Allogeneic Stem Cell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Allogeneic Stem Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Musculoskeletal Disorder
Wounds & Injuries
Cardiovascular Diseases
Others
Global Allogeneic Stem Cell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Allogeneic Stem Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Allogeneic Stem Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Allogeneic Stem Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Allogeneic Stem Cell Therapy, market overview.
Chapter 2: Global Allogeneic Stem Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Allogeneic Stem Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Allogeneic Stem Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Allogeneic Stem Cell Therapy Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Allogeneic Stem Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Allogeneic Stem Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Allogeneic Stem Cell Therapy Overall Market Size
2.1 Global Allogeneic Stem Cell Therapy Market Size: 2022 VS 2029
2.2 Global Allogeneic Stem Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Allogeneic Stem Cell Therapy Players in Global Market
3.2 Top Global Allogeneic Stem Cell Therapy Companies Ranked by Revenue
3.3 Global Allogeneic Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Allogeneic Stem Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Allogeneic Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Allogeneic Stem Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Allogeneic Stem Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Allogeneic Stem Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Allogeneic Stem Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 Adult Stem Cell Therapy
4.1.3 Human Embryonic Stem Cell Therapy
4.1.4 Induced Pluripotent Stem Cell Therapy
4.1.5 Others
4.2 By Type - Global Allogeneic Stem Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Allogeneic Stem Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Allogeneic Stem Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Allogeneic Stem Cell Therapy Market Size, 2022 & 2029
5.1.2 Musculoskeletal Disorder
5.1.3 Wounds & Injuries
5.1.4 Cardiovascular Diseases
5.1.5 Others
5.2 By Application - Global Allogeneic Stem Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Allogeneic Stem Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Allogeneic Stem Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Allogeneic Stem Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global Allogeneic Stem Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Allogeneic Stem Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Allogeneic Stem Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Allogeneic Stem Cell Therapy Revenue, 2018-2029
6.3.2 US Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.3.3 Canada Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Allogeneic Stem Cell Therapy Revenue, 2018-2029
6.4.2 Germany Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.4.3 France Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.4.5 Italy Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.4.6 Russia Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Allogeneic Stem Cell Therapy Revenue, 2018-2029
6.5.2 China Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.5.3 Japan Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.5.6 India Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Allogeneic Stem Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Allogeneic Stem Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.7.3 Israel Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Allogeneic Stem Cell Therapy Market Size, 2018-2029
6.7.5 UAE Allogeneic Stem Cell Therapy Market Size, 2018-2029
7 Allogeneic Stem Cell Therapy Companies Profiles
7.1 Escape Therapeutics, Inc.
7.1.1 Escape Therapeutics, Inc. Company Summary
7.1.2 Escape Therapeutics, Inc. Business Overview
7.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Major Product Offerings
7.1.4 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Escape Therapeutics, Inc. Key News & Latest Developments
7.2 Lonza Group Ltd.
7.2.1 Lonza Group Ltd. Company Summary
7.2.2 Lonza Group Ltd. Business Overview
7.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Major Product Offerings
7.2.4 Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Lonza Group Ltd. Key News & Latest Developments
7.3 Osiris Therapeutics (Smith & Nephew)
7.3.1 Osiris Therapeutics (Smith & Nephew) Company Summary
7.3.2 Osiris Therapeutics (Smith & Nephew) Business Overview
7.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Major Product Offerings
7.3.4 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Osiris Therapeutics (Smith & Nephew) Key News & Latest Developments
7.4 NuVasive
7.4.1 NuVasive Company Summary
7.4.2 NuVasive Business Overview
7.4.3 NuVasive Allogeneic Stem Cell Therapy Major Product Offerings
7.4.4 NuVasive Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 NuVasive Key News & Latest Developments
7.5 Chiesi Pharmaceuticals
7.5.1 Chiesi Pharmaceuticals Company Summary
7.5.2 Chiesi Pharmaceuticals Business Overview
7.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Major Product Offerings
7.5.4 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Chiesi Pharmaceuticals Key News & Latest Developments
7.6 JCR Pharmaceutical
7.6.1 JCR Pharmaceutical Company Summary
7.6.2 JCR Pharmaceutical Business Overview
7.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Major Product Offerings
7.6.4 JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 JCR Pharmaceutical Key News & Latest Developments
7.7 Pharmicell
7.7.1 Pharmicell Company Summary
7.7.2 Pharmicell Business Overview
7.7.3 Pharmicell Allogeneic Stem Cell Therapy Major Product Offerings
7.7.4 Pharmicell Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Pharmicell Key News & Latest Developments
7.8 Anterogen
7.8.1 Anterogen Company Summary
7.8.2 Anterogen Business Overview
7.8.3 Anterogen Allogeneic Stem Cell Therapy Major Product Offerings
7.8.4 Anterogen Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Anterogen Key News & Latest Developments
7.9 MolMed S.p.A.
7.9.1 MolMed S.p.A. Company Summary
7.9.2 MolMed S.p.A. Business Overview
7.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Major Product Offerings
7.9.4 MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 MolMed S.p.A. Key News & Latest Developments
7.10 Takeda (TiGenix)
7.10.1 Takeda (TiGenix) Company Summary
7.10.2 Takeda (TiGenix) Business Overview
7.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Major Product Offerings
7.10.4 Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Takeda (TiGenix) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Allogeneic Stem Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Allogeneic Stem Cell Therapy Market Drivers in Global Market
Table 3. Allogeneic Stem Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Allogeneic Stem Cell Therapy in Global Market
Table 5. Top Allogeneic Stem Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Allogeneic Stem Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Allogeneic Stem Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Allogeneic Stem Cell Therapy Product Type
Table 9. List of Global Tier 1 Allogeneic Stem Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Allogeneic Stem Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Allogeneic Stem Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Allogeneic Stem Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Allogeneic Stem Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Allogeneic Stem Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Allogeneic Stem Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Allogeneic Stem Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Escape Therapeutics, Inc. Company Summary
Table 31. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product Offerings
Table 32. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Escape Therapeutics, Inc. Key News & Latest Developments
Table 34. Lonza Group Ltd. Company Summary
Table 35. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product Offerings
Table 36. Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Lonza Group Ltd. Key News & Latest Developments
Table 38. Osiris Therapeutics (Smith & Nephew) Company Summary
Table 39. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product Offerings
Table 40. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Osiris Therapeutics (Smith & Nephew) Key News & Latest Developments
Table 42. NuVasive Company Summary
Table 43. NuVasive Allogeneic Stem Cell Therapy Product Offerings
Table 44. NuVasive Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. NuVasive Key News & Latest Developments
Table 46. Chiesi Pharmaceuticals Company Summary
Table 47. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product Offerings
Table 48. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Chiesi Pharmaceuticals Key News & Latest Developments
Table 50. JCR Pharmaceutical Company Summary
Table 51. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product Offerings
Table 52. JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. JCR Pharmaceutical Key News & Latest Developments
Table 54. Pharmicell Company Summary
Table 55. Pharmicell Allogeneic Stem Cell Therapy Product Offerings
Table 56. Pharmicell Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Pharmicell Key News & Latest Developments
Table 58. Anterogen Company Summary
Table 59. Anterogen Allogeneic Stem Cell Therapy Product Offerings
Table 60. Anterogen Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Anterogen Key News & Latest Developments
Table 62. MolMed S.p.A. Company Summary
Table 63. MolMed S.p.A. Allogeneic Stem Cell Therapy Product Offerings
Table 64. MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. MolMed S.p.A. Key News & Latest Developments
Table 66. Takeda (TiGenix) Company Summary
Table 67. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product Offerings
Table 68. Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda (TiGenix) Key News & Latest Developments
List of Figures
Figure 1. Allogeneic Stem Cell Therapy Segment by Type in 2022
Figure 2. Allogeneic Stem Cell Therapy Segment by Application in 2022
Figure 3. Global Allogeneic Stem Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Allogeneic Stem Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Allogeneic Stem Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Allogeneic Stem Cell Therapy Revenue in 2022
Figure 8. By Type - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Allogeneic Stem Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. NuVasive Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pharmicell Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Anterogen Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
